Showing results (251-260 of 413) with videos related to

Sort By:
Pageof 42
Bone Marrow Transplantation|October 1, 1992
Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patientsJ H Essell, J M Thompson, G S Harman, et al.
Experimental Eye Research|April 17, 2007
Two-dimensional order in mammalian pre-ocular tear filmP G Petrov, J M Thompson, I B Abdul Rahman, et al.
Cancer|July 1, 1988
Acute neurologic dysfunction after high-dose etoposide therapy for malignant gliomaR S Leff, J M Thompson, M B Daly, et al.
Blood|May 15, 1992
Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamideJ H Essell, J M Thompson, G S Harman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 1999
Matched-pair analysis of hematopoietic progenitor cell mobilization using G-CSF vs. cyclophosphamide, etoposide, and G-CSF: enhanced CD34+ cell collections are not necessarily cost-effectiveL P Akard, J M Thompson, M J Dugan, et al.
Experimental Gerontology|March 31, 2004
Validation of a new highly standardised, lab-independent whole-blood leukocyte function assay for clinical trials (ILCS)M Schmolz, T L Hurst, D M Bailey, et al.
Gene Therapy|April 20, 2007
Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cellsL Sanchez-Perez, M Gough, J Qiao, et al.
Oncogene|November 15, 2016
Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinomaJ M Thompson, Q H Nguyen, M Singh, et al.
Cancer|March 15, 1983
Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancerL M Itri, R J Gralla, D P Kelsen, et al.
The Journal of Rheumatology|November 1, 1991
Ankylosing spondylitis antirheumatic drug trials. II. Tables for calculating sample size for clinical trialsN Bellamy, W W Buchanan, J M Esdaile, et al.
Pageof 42